Furthermore, many studies have found that the expression level of MCT4 is closely related to the progression of tumors, such as hepatocellular carcinoma 77, colorectal cancer 78, pancreatic cancer 70, cervical carcinoma 79, and ovarian carcinoma 80. This evidence concerns the gene SLC16A3 and hepatocellular carcinoma.